Clinical Trial Update: Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravitreal bevacizumab and triamcinolone associated with laser photocoagulation for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED